Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation
VG Valentine, D Weill, MR Gupta, B Raper… - The Journal of heart and …, 2008 - Elsevier
BACKGROUND: Universal ganciclovir (GCV) prophylaxis is a strategy aimed at reducing
cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans
syndrome (BOS). However, the optimal duration of GCV prophylaxis remains unclear. We
report our experience with GCV prophylaxis administered indefinitely and its effect on CMV
pneumonitis, BOS and survival after lung transplantation (LT). METHODS: One hundred fifty-
one patients surviving> 100 days after LT were analyzed. GCV was given to 130 CMV donor …
cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans
syndrome (BOS). However, the optimal duration of GCV prophylaxis remains unclear. We
report our experience with GCV prophylaxis administered indefinitely and its effect on CMV
pneumonitis, BOS and survival after lung transplantation (LT). METHODS: One hundred fifty-
one patients surviving> 100 days after LT were analyzed. GCV was given to 130 CMV donor …
以上显示的是最相近的搜索结果。 查看全部搜索结果